202 related articles for article (PubMed ID: 23894429)
1. Mutation types and aging differently affect revertant fiber expansion in dystrophic mdx and mdx52 mice.
Echigoya Y; Lee J; Rodrigues M; Nagata T; Tanihata J; Nozohourmehrabad A; Panesar D; Miskew B; Aoki Y; Yokota T
PLoS One; 2013; 8(7):e69194. PubMed ID: 23894429
[TBL] [Abstract][Full Text] [Related]
2. Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background.
Rodrigues M; Echigoya Y; Maruyama R; Lim KR; Fukada SI; Yokota T
Sci Rep; 2016 Dec; 6():38371. PubMed ID: 27924830
[TBL] [Abstract][Full Text] [Related]
3. Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion.
Lu QL; Morris GE; Wilton SD; Ly T; Artem'yeva OV; Strong P; Partridge TA
J Cell Biol; 2000 Mar; 148(5):985-96. PubMed ID: 10704448
[TBL] [Abstract][Full Text] [Related]
4. Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration.
Yokota T; Lu QL; Morgan JE; Davies KE; Fisher R; Takeda S; Partridge TA
J Cell Sci; 2006 Jul; 119(Pt 13):2679-87. PubMed ID: 16757519
[TBL] [Abstract][Full Text] [Related]
5. Suppression of revertant fibers in mdx mice by expression of a functional dystrophin.
Crawford GE; Lu QL; Partridge TA; Chamberlain JS
Hum Mol Genet; 2001 Nov; 10(24):2745-50. PubMed ID: 11734539
[TBL] [Abstract][Full Text] [Related]
6. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y
Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660
[TBL] [Abstract][Full Text] [Related]
7. Morpholino-induced exon skipping stimulates cell-mediated and humoral responses to dystrophin in mdx mice.
Vila MC; Novak JS; Benny Klimek M; Li N; Morales M; Fritz AG; Edwards K; Boehler JF; Hogarth MW; Kinder TB; Zhang A; Mazala D; Fiorillo AA; Douglas B; Chen YW; van den Anker J; Lu QL; Hathout Y; Hoffman EP; Partridge TA; Nagaraju K
J Pathol; 2019 Jul; 248(3):339-351. PubMed ID: 30883742
[TBL] [Abstract][Full Text] [Related]
8. Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery.
Aoki Y; Yokota T; Nagata T; Nakamura A; Tanihata J; Saito T; Duguez SM; Nagaraju K; Hoffman EP; Partridge T; Takeda S
Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13763-8. PubMed ID: 22869723
[TBL] [Abstract][Full Text] [Related]
9. L-type Ca2+ channel function is linked to dystrophin expression in mammalian muscle.
Friedrich O; von Wegner F; Chamberlain JS; Fink RH; Rohrbach P
PLoS One; 2008 Mar; 3(3):e1762. PubMed ID: 18516256
[TBL] [Abstract][Full Text] [Related]
10. Revertant fibers in the mdx murine model of Duchenne muscular dystrophy: an age- and muscle-related reappraisal.
Pigozzo SR; Da Re L; Romualdi C; Mazzara PG; Galletta E; Fletcher S; Wilton SD; Vitiello L
PLoS One; 2013; 8(8):e72147. PubMed ID: 24015212
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
[TBL] [Abstract][Full Text] [Related]
12. In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.
Aoki Y; Nakamura A; Yokota T; Saito T; Okazawa H; Nagata T; Takeda S
Mol Ther; 2010 Nov; 18(11):1995-2005. PubMed ID: 20823833
[TBL] [Abstract][Full Text] [Related]
13. Persistent upregulation of the β-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle.
Randazzo D; Khalique U; Belanto JJ; Kenea A; Talsness DM; Olthoff JT; Tran MD; Zaal KJ; Pak K; Pinal-Fernandez I; Mammen AL; Sackett D; Ervasti JM; Ralston E
Hum Mol Genet; 2019 Apr; 28(7):1117-1135. PubMed ID: 30535187
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
15. Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?
Wilton SD; Dye DE; Blechynden LM; Laing NG
Neuromuscul Disord; 1997 Jul; 7(5):329-35. PubMed ID: 9267847
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice.
Aoki Y; Nagata T; Yokota T; Nakamura A; Wood MJ; Partridge T; Takeda S
Hum Mol Genet; 2013 Dec; 22(24):4914-28. PubMed ID: 23882132
[TBL] [Abstract][Full Text] [Related]
17. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
18. Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy.
van Westering TLE; Johansson HJ; Hanson B; Coenen-Stass AML; Lomonosova Y; Tanihata J; Motohashi N; Yokota T; Takeda S; Lehtiö J; Wood MJA; El Andaloussi S; Aoki Y; Roberts TC
Mol Cell Proteomics; 2020 Dec; 19(12):2047-2068. PubMed ID: 32994316
[TBL] [Abstract][Full Text] [Related]
19. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
Williams JH; Sirsi SR; Latta DR; Lutz GJ
Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666
[TBL] [Abstract][Full Text] [Related]
20. Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.
Rodrigues M; Echigoya Y; Fukada SI; Yokota T
J Neuromuscul Dis; 2016 Mar; 3(1):29-48. PubMed ID: 27854202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
